Tang Yongmin, Xu Xiaojun, Song Hua, Yang Shilong, Shi Shuwen, Wei Jian
Division of Hematology-Oncology, Children's Hospital Zhejiang University School of Medicine, Hangzhou, PR China.
Pediatr Blood Cancer. 2008 Sep;51(3):380-6. doi: 10.1002/pbc.21629.
To retrospectively determine the treatment outcome and causes of treatment failure of ALL children treated in a single institution at East China.
Between January 1998 and October 2004, 346 newly diagnosed ALL patients <or=16 years were admitted to our hospital. Of these, 248 patients received modified National Protocol of Childhood ALL in China 1997 (NPCAC97) for at least 2 weeks of treatment and were eligible for protocol evaluation.
Among the 346 newly diagnosed patients, 167 (48.3%) stopped treatment either at diagnosis or during therapy. The abandonment rates for urban area group (UAG) and rural area group (RAG) were 25.3% and 57.3%, respectively (P < 0.0001). The 5-year event-free survival (EFS) rate for the entire cohort was 38.5 +/- 2.7%. For 248 evaluable patients, the remission rate was 97.2%. The 5-year EFS and overall survival (OS) rates were 70.7 +/- 3.6% and 82.1 +/- 3.0%, respectively. The 5-year EFS for standard-risk group (n = 196) was significantly higher than that of high-risk group (n = 52) (75.9 +/- 3.9% vs. 50.7 +/- 8.0%, P = 0.0002). Prognostic factor analysis showed that poor response to remission induction therapy and a poor socioeconomic status were predictive for an inferior outcome.
Abandonment of chemotherapy was the most common cause of treatment failure, which was strongly related to poor socioeconomic status and financial support. For patients who could adhere to the treatment protocol, a relatively good outcome was achieved.
回顾性分析中国东部某单一机构治疗的所有儿童急性淋巴细胞白血病(ALL)患者的治疗结局及治疗失败原因。
1998年1月至2004年10月,346例年龄≤16岁新诊断的ALL患者入住我院。其中,248例患者接受了1997年中国儿童ALL改良国家方案(NPCAC97)治疗至少2周,符合方案评估标准。
346例新诊断患者中,167例(48.3%)在诊断时或治疗期间停止治疗。城区组(UAG)和农村地区组(RAG)的放弃率分别为25.3%和57.3%(P<0.0001)。整个队列的5年无事件生存率(EFS)为38.5±2.7%。248例可评估患者的缓解率为97.2%。5年EFS和总生存率(OS)分别为70.7±3.6%和82.1±3.0%。标准危险组(n = 196)的5年EFS显著高于高危组(n = 52)(75.9±3.9%对50.7±8.0%,P = 0.0002)。预后因素分析表明,缓解诱导治疗反应不佳和社会经济地位差预示预后不良。
放弃化疗是治疗失败的最常见原因,这与社会经济地位差和经济支持密切相关。对于能够坚持治疗方案的患者,可取得相对较好的结局。